A unique cytotoxic CD4(+) T cell‐signature defines critical COVID‐19

por Baird, Sarah, Ashley, Caroline L, Marsh‐Wakefield, Felix, Alca, Sibel, Ashhurst, Thomas M, Ferguson, Angela L, Lukeman, Hannah, Counoupas, Claudio, Post, Jeffrey J, Konecny, Pamela, Bartlett, Adam, Martinello, Marianne, Bull, Rowena A, Lloyd, Andrew, Grey, Alice, Hutchings, Owen, Palendira, Umaimainthan, Britton, Warwick J, Steain, Megan, Triccas, James A
Publicado 2023

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens

por Counoupas, Claudio, Pino, Paco, Stella, Alberto O., Ashley, Caroline, Lukeman, Hannah, Bhattacharyya, Nayan D., Tada, Takuya, Anchisi, Stephanie, Metayer, Charles, Martinis, Jacopo, Aggarwal, Anupriya, Dcosta, Belinda M., Britton, Warwick J., Kint, Joeri, Wurm, Maria J., Landau, Nathaniel R., Steain, Megan, Turville, Stuart G., Wurm, Florian M., David, Sunil A., Triccas, James A.
Publicado 2022